Gergen Mark J

CIK 00013731104 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001373110

Recent Transactions

50 trades

Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−172,600→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−75,000→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−48,115→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−364,060→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−342,000→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−518,500→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2025-01-08−240,721→ 0 total
Disposition from Tender
Poseida Therapeutics, Inc.
Common Stock
2025-01-08−636,726→ 0 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2025-01-02$9.60/sh−23,313→ 630,726 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2024-12-10$2.78/sh+30,000→ 681,291 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2024-12-10$9.46/sh−30,000→ 651,291 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-12-10−30,000→ 96,372 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2024-11-26$2.78/sh+30,000→ 681,291 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2024-11-26−30,000→ 126,372 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2024-11-26$9.27/sh−30,000→ 651,291 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-03-01$4.13/sh−34,157→ 651,291 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2024-02-01$3.41/sh−47,162→ 685,448 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-01-02+125,000→ 732,610 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2024-01-02+172,600→ 172,600 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-03-01+269,586→ 601,610 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-03-01+364,060→ 364,060 total
Tax Payment
Poseida Therapeutics, Inc.
Common Stock
2023-02-01$7.00/sh−31,819→ 330,314 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01+518,500→ 518,500 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-02-01+357,200→ 357,200 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-04+342,000→ 342,000 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2020-07-09+75,000→ 75,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2017-02-22+45,568→ 45,568 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2017-02-22+72,925→ 72,925 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Options to Purchase Common Stock
2016-09-01+333,890→ 333,890 total
Award
Mirati Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-22+60,000→ 60,000 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Incentive Stock Option (right to buy)
2016-01-15+5,000→ 127,000 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2016-01-15$25.92/sh+10,000→ 117,000 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2016-01-15$8.50/sh+5,000→ 5,748 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2016-01-15$25.92/sh−10,000→ 5,748 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2016-01-15$8.50/sh+10,000→ 15,748 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2015-02-04+30,000→ 30,000 total
Award
Mirati Therapeutics, Inc.
Stock Option (Right to Buy)
2013-07-17+132,000→ 132,000 total
Disposition from Tender
AMYLIN PHARMACEUTICALS INC
Common Stock
2012-08-08$31.00/sh−2,135.7→ 473.3 total
Other
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08$31.00/sh−8,379→ 0 total
Other
AMYLIN PHARMACEUTICALS INC
Common Stock
2012-08-08$31.00/sh+53,181→ 53,181 total
Other
AMYLIN PHARMACEUTICALS INC
Common Stock
2012-08-08$31.00/sh−53,181→ 0 total
Disposition from Tender
AMYLIN PHARMACEUTICALS INC
Common Stock
2012-08-08$31.00/sh−473.3→ 0 total
Expiration (Short)
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08−2,711→ 0 total
Other
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08$31.00/sh−7,533→ 0 total
Expiration (Short)
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08−2,585→ 0 total
Other
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2012-08-08$31.00/sh−51,561→ 0 total
Disposition from Tender
AMYLIN PHARMACEUTICALS INC
Common Stock
2012-08-08$31.00/sh−64,338.2→ 412 total
Other
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08$31.00/sh−4,020→ 0 total
Other
AMYLIN PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
2012-08-08$31.00/sh−6,748→ 0 total
Other
AMYLIN PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
2012-08-08$31.00/sh−62,467→ 0 total

Companies

Recent Filings

Address

9360 TOWNE CENTRE DR

SAN DIEGO, CA, 92121

View on SEC.gov